市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | Neuronetics, Inc. | 混合的 | 混合的 |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | 1.0 |
| 价格波动 | -4.5 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | 4.0 |
| 相对估值 | NA |
| 财务健康 | -2.6 |
| 宏观环境 | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| 平均 | -0.48 |
|
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 9.17% |
| 机构持股比例 | 62.81% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Madryn Asset Management, Lp | 30 Jun 2026 | 18,540,488 |
| Wexford Capital Lp | 30 Jun 2026 | 2,002,625 |
| Fourworld Capital Management Llc | 30 Jun 2026 | 1,744,142 |
| Ikarian Capital, Llc | 30 Jun 2026 | 701,182 |
| Hightower Advisors, Llc | 30 Jun 2026 | 563,741 |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| CHERNETT JOREY | 2.25 | - | 18,000 | 40,500 |
| 累积净数量 | 18,000 | |||
| 累积净值 ($) | 40,500 | |||
| 累积平均购买 ($) | 2.25 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| CHERNETT JOREY | 30 Oct 2026 | 买 (+) | 18,000 | 2.25 | 40,500 |
投资组合